METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1
Clinical trials for METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1 explained in plain language.
Never miss a new study
Get alerted when new METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1 trials appear
Sign up with your email to follow new studies for METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for slowing advanced neuroendocrine tumors in major trial
Disease control OngoingThis study is testing if a drug called cabozantinib can slow the growth of advanced neuroendocrine tumors better than a placebo (inactive pill). It is for about 298 patients whose cancer has continued to grow despite receiving at least one prior standard treatment. The main goal …
Matched conditions: METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug trial aims to halt rare Cancer's spread
Disease control OngoingThis study is testing whether a drug called pazopanib can slow or stop the growth of carcinoid tumors that are getting worse. It compares pazopanib against a placebo (inactive pill) in 171 patients whose tumors have progressed. The main goal is to see if the drug helps patients l…
Matched conditions: METASTATIC DIGESTIVE SYSTEM NEUROENDOCRINE TUMOR G1
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC